Review Article Volume 9 Issue 1
Received: January 27, 2026 | Published: February 16, 2026
Citation: Lu DY, Wu HY, Che JY, et al. Emerging medications for suicide prediction and therapeutic strategies. Hos Pal Med Int Jnl. 2026;9(1):8-12. DOI: 10.15406/hpmij.2026.09.00283
Suicide has a high rate of human deaths (0.5-1.2 million deaths annually). It is suggested that large number of different factors may drive human suicide processes from thoughts to deaths. It is urgently needed for developing new therapies for human suicide. Good therapies will not success without complete understanding of its pathogenic roots. Unfortunately, the pathogenic root of human suicide has not been fully revealed. Among different risk factors, high quality clinical suicide prediction, prevention and treatment is needed. Human suicide prediction and prevention study has been translated from intangible entities into formal medication. A great deal of connection and unity between neurobiological aberration, different symptoms, and death cases is indispensable. To cope with these advances, public healthcare, biomedical foundation, and clinical databases are analyzed in this article.
Keywords: human suicide, neurobiology, psychopharmacology, drug develop, CNS disease, suicide prediction
©2026 Lu, et al. This is an open access article distributed under the terms of the, which permits unrestricted use, distribution, and build upon your work non-commercially.